Skip to content

Study on TCM constitution analysis and related protection of susceptible population of Acute mountain sickness

Study on TCM constitution analysis and related protection of susceptible population of Acute mountain sickness

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2200005850
Enrollment
Unknown
Registered
2022-04-12
Start date
2022-05-01
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute altitude sickness

Interventions

phlegm-dampness quality group:
rhodiola capsule group:
Yang deficiency quality group:
blood stasis quality group:
Qi stagnation quality group:
damp-heat quality group:
Peaceful quality group:Non-decocted granule of Chinese medicine formula
special quality group:
Yin deficiency quality group:
Qi deficiency quality group:

Sponsors

Second Affiliated Hospital of PLA Army Military Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: The plain advanced to a plateau of more than 3,000 meters; Living in an area with an elevation of 500m or less, no plateau living or working experience; There were no obvious abnormalities in physical examination before entering the plateau. The age ranges from 18 to 65; Can persist in treatment and sign informed consent.

Exclusion criteria

Exclusion criteria: Patients with chronic headache, dizziness and other symptoms before entering the plateau; Patients with cardiovascular diseases before entering the plateau; Patients with respiratory diseases before entering the plateau; Patients with digestive diseases before entering the plateau; Having mental illness or symptoms; Pregnant or lactating women; Taking another investigational drug or participating in another clinical trial in the 3 months prior to enrollment; For any reason not suitable for the study or not considered suitable for inclusion in this study.

Design outcomes

Primary

MeasureTime frame
Acute mountain sickness identification Scale;TCM constitution identification scale;

Countries

China

Contacts

Public ContactXu Zihui
zihuixu@yeah.net13896081919

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026